Home Newsfeeds Redburn Partners Downgrades PayPal Holdings to Neutral

Redburn Partners Downgrades PayPal Holdings to Neutral

Redburn Partners analyst Fahed Kunwar downgrades PayPal Holdings (NASDAQ:PYPL) from Buy to Neutral.

byBenzinga Newsdesk

July 8, 2022

1 minute read

Redburn Partners analyst Fahed Kunwar downgrades PayPal Holdings (NASDAQ:PYPL) from Buy to Neutral.

Morgan Stanley Maintains Equal-Weight on Finance of America, Lowers Price Target to $1.5

By Benzinga Newsdesk

December 16, 9:53 AM

Morgan Stanley analyst James Faucette maintains Finance of America (NYSE:FOA) with a Equal-Weight and lowers the price target from $2 to $1.5.

FOA

Wedbush’s Ives Projects 16% Upside For Palo Alto Stock, Sets Bullish Target At $425: ‘Golden Age Of Cybersecurity Is On The Doorstep’

By Benzinga Neuro

February 16, 2:17 AM

Ives expressed his upbeat outlook for Palo Alto Networks on X, formerly Twitter, stating that the price target has been raised to $425.

PANW

Paratek Pharmaceuticals Announces Top Line Data From Pilot Efficacy Study For The Treatment Of Pulmonary Anthrax And Acceptance Of The Second Procurement Of NUZYRA Under BARDA Project BioShield

By Benzinga Newsdesk

December 19, 8:37 AM

Paratek Pharmaceuticals, Inc. (NASDAQ:PRTK) today announced positive top line data from a pilot rabbit efficacy study evaluating NUZYRA’s effectiveness in the treatment of pulmonary anthrax. In the study, a 100%

PRTK

Fed’s Waller Says Market Expectations Provide Confidence That Fed Is On Right Path; Says Investors Expect Inflation-Adjusted Policy Rate Of 0.7% In Mid-2023, 1% In Mid-2024

By Benzinga Newsdesk

July 14, 11:01 AM

-Reuters

SPY

Redburn Partners Downgrades PayPal Holdings to Neutral

Related Posts

Morgan Stanley Maintains Equal-Weight on Finance of America, Lowers Price Target to $1.5

Wedbush’s Ives Projects 16% Upside For Palo Alto Stock, Sets Bullish Target At $425: ‘Golden Age Of Cybersecurity Is On The Doorstep’

Paratek Pharmaceuticals Announces Top Line Data From Pilot Efficacy Study For The Treatment Of Pulmonary Anthrax And Acceptance Of The Second Procurement Of NUZYRA Under BARDA Project BioShield

Fed’s Waller Says Market Expectations Provide Confidence That Fed Is On Right Path; Says Investors Expect Inflation-Adjusted Policy Rate Of 0.7% In Mid-2023, 1% In Mid-2024